AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Metblist 500 SR Tablet

Prescription Icon
Prescription Required

Marketer

Smartway Wellness

Salt Composition

Metformin (500mg)

Overview Metblist 500 SR Tablet

Diabex 500 Extended Release tablets manage type 2 diabetes mellitus by regulating blood glucose, mitigating associated complications. This medication also addresses Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize nausea or stomach upset, consume Diabex 500 ER with food. Consistent daily dosing is crucial for efficacy; discontinue only under physician guidance. Maintaining a healthy diet and exercise regimen, as prescribed, is essential for successful diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, gas, fatigue, indigestion, abdominal discomfort, headache, and appetite loss. Concurrent use with other diabetes medications, alcohol, or missed meals may trigger hypoglycemia (low blood sugar). Regular blood glucose monitoring is vital. Prior to starting Diabex 500 ER, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical consultation before use. Kidney function assessment will precede treatment initiation. Limit alcohol consumption to reduce the risk of adverse reactions.

Uses of Metblist 500 SR Tablet

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Metblist 500 SR Tablet:

Follow your physician's instructions or consult the product label for proper administration. Consume Metblist 500 SR Tablet with a meal.

Common Side effects of Metblist 500 SR Tablet:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metblist 500 SR Tablet:

Follow your doctor's instructions or consult the product label for usage guidelines. Administer Metblist 500 SR Tablet with food.

How Metblist 500 SR Tablet works:

GlucoMet 500 Extended-Release tablets are a biguanide-class antidiabetic agent. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metblist 500 SR Tablet is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

Employing Metblist 500 SR Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; despite this, data from human trials remains scarce.

Breast feedingBreast feedingCAUTION

Use of Metblist 500 SR Tablet requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metblist 500 SR Tablet cautiously, potentially requiring dosage modification under medical supervision. Metblist 500 SR Tablet is contraindicated in patients with severe kidney disease.

LiverLiverUNSAFE

Individuals with liver impairment should likely abstain from Metblist 500 SR Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Metblist 500 SR Tablet :

Should you forget to take your Metblist 500 SR Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Metblist 500 SR Tablet

LabelValue
Chemical Classification Biguanide Analog
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Metblist 500 SR Tablet

In type 2 diabetes, the body doesn't respond effectively to its own insulin, leading to high blood sugar. Metblist 500 SR Tablet works in multiple ways to lower blood glucose. It reduces glucose production by the liver, slows glucose absorption from the intestines, and enhances insulin sensitivity in organs and muscles, improving glucose uptake and the body's response to naturally produced insulin.
Metblist 500 SR Tablets have demonstrated weight loss benefits in overweight and obese individuals, including those at risk for diabetes or with insulin sensitivity/resistance. However, do not begin taking this medication for weight loss without first consulting your physician.
Metblist 500 SR Tablet is a leading initial treatment for high blood sugar. It manages blood sugar by enhancing insulin sensitivity, reducing liver glucose production, and limiting intestinal sugar absorption. Uniquely, unlike many other oral antidiabetics, Metblist 500 SR Tablet, when used alone, seldom causes hypoglycemia by avoiding excess insulin secretion from the pancreas. Beyond blood sugar control, it also aids in weight management.
Metblist 500 SR Tablets generally don't cause drowsiness and are well-tolerated. Rarely, however, they may lead to sleep disturbances or insomnia. Excessive sleepiness could indicate a serious side effect, lactic acidosis, especially if you have kidney problems. Report any unusual tiredness or sleepiness to your doctor immediately.
Take Metblist 500 SR tablets with food. Swallow whole with water; do not crush or chew. Follow your doctor's instructions: one tablet daily is best taken with breakfast; two tablets daily, one with breakfast and one with dinner; three tablets daily, with breakfast, lunch, and dinner. Taking the tablets with meals minimizes potential digestive issues such as indigestion, nausea, vomiting, diarrhea, stomach upset, and appetite loss.
Type 2 diabetes results from insufficient insulin production or impaired insulin response, leading to elevated blood sugar. Metblist 500 SR Tablet addresses this by reducing liver glucose production, decreasing intestinal glucose absorption, and enhancing insulin sensitivity in organs and muscles. This improves glucose uptake from the blood and overall insulin responsiveness.
Metblist 500 SR Tablets have demonstrated weight loss benefits in overweight and obese individuals, including those at risk for diabetes or with insulin resistance. However, never begin taking this medication for weight loss without first consulting your doctor.
Metblist 500 SR Tablet is a frontline treatment for high blood sugar, effectively managing blood glucose levels. It enhances insulin sensitivity, reduces liver glucose production, and minimizes intestinal sugar absorption. Unlike many other oral antidiabetic medications, Metblist 500 SR Tablet, when used alone, infrequently causes hypoglycemia by preventing excessive insulin release. Beyond glycemic control, it also aids in weight management.
Metblist 500 SR Tablets generally don't cause drowsiness and are well-tolerated. Rarely, however, they may lead to sleep disturbances or insomnia. Excessive sleepiness could indicate a serious side effect, lactic acidosis, especially if you have kidney problems. Consult your doctor immediately if you experience unusual tiredness or sleepiness while using Metblist 500 SR Tablets.
Take Metblist 500 SR tablets with or after food. Swallow the tablets whole with water; do not crush or chew them. For single daily doses, take it with breakfast. For two daily doses, take one with breakfast and one with dinner. For three daily doses, take one with breakfast, one with lunch, and one with dinner. Taking Metblist 500 SR with meals minimizes potential digestive upset, such as indigestion, nausea, vomiting, diarrhea, stomach pain, and loss of appetite.
Type 2 diabetes results from insufficient insulin production or impaired insulin response, leading to elevated blood sugar. Metblist 500 SR Tablet addresses this by reducing liver glucose production, decreasing intestinal glucose absorption, and enhancing insulin sensitivity in organs and muscles. This improves glucose uptake from the blood and strengthens the body's natural insulin response.
Metblist 500 SR Tablets have demonstrated weight loss benefits in overweight and obese individuals, including those at risk for diabetes or with insulin sensitivity/resistance. However, never begin taking this medication for weight loss without first consulting your doctor.
Metblist 500 SR Tablet is a frontline treatment for high blood sugar, effectively managing blood glucose levels. It enhances insulin sensitivity, reduces liver glucose production, and limits intestinal sugar absorption. Unlike many other oral antidiabetic medications, Metblist 500 SR Tablet, when used alone, seldom causes hypoglycemia by preventing excessive insulin release. Beyond blood sugar control, it also aids in weight management.
Metblist 500 SR Tablets typically don't cause drowsiness and are generally well-tolerated. Rarely, however, sleep disturbances or insomnia may occur. Unusual sleepiness could indicate a serious side effect, lactic acidosis, especially if you have kidney problems. Consult your doctor if you experience fatigue or drowsiness while using Metblist 500 SR Tablets.
Take Metblist 500 SR tablets with or after food. Swallow whole with water; do not crush or chew. For a once-daily dose, take it in the morning with breakfast. If prescribed twice daily, take one with breakfast and one with dinner. For three doses daily, take one with breakfast, one with lunch, and one with dinner. Taking Metblist 500 SR with meals minimizes potential digestive upset, such as indigestion, nausea, vomiting, diarrhea, stomach pain, and appetite loss.
Metblist 500 SR Tablet
19
MRP 22
13% off